On CNBC's “Halftime Report Final Trades,” Jason Snipe, founder and chief investment officer of Odyssey Capital Advisors, picked the iShares Biotechnology ETF (NYSE:IBB), and recommended staying long ...
Source LinkOn CNBC's “Halftime Report Final Trades,” Jason Snipe, founder and chief investment officer of Odyssey Capital Advisors, picked the iShares Biotechnology ETF (NYSE:IBB), and recommended staying long ...
Source Link
Comments